Pharmaceuticals & Vaccines – Innovating from Lab to Market

Halifax is advancing pharmaceuticals, vaccines and biotechnology from early research through clinical testing and commercialization. The city’s collaborative ecosystem connects researchers, hospitals, health-system partners, and growing biopharma companies working in vaccine development, immunotherapy, infectious disease, and drug discovery.

Nova Scotia Health supports approximately 400 clinical trials at any given time, while the Atlantic Clinical Trials Network extends access across a regional population of roughly 2.5 million people. The Canadian Center for Vaccinology adds more than 20 investigators working across vaccine discovery, clinical evaluation, implementation, policy and ethics, strengthening Halifax’s role as a launchpad for health innovations with national and global potential.